Phase II trial of pazopanib and weekly paclitaxel in metastatic urothelial cancer (UC). Srinivas, S., Narayanan, S., Harshman, L., Lam, A. P., Vaishampayan, U. N., Haas, D., Poushnejad, S., Pachynski, R. AMER SOC CLINICAL ONCOLOGY. 2014

View details for DOI 10.1200/jco.2014.32.4_suppl.299

View details for Web of Science ID 000335318100300